Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.76 |
| ▸ | CA1 | P00915 | 7/20 | 0.76 |
| ▸ | CA2 | P00918 | 7/20 | 0.76 |
| ▸ | CA7 | P43166 | 7/20 | 0.76 |
| ▸ | CA9 | Q16790 | 7/20 | 0.76 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 0.76 |
| ▸ | HCAR1 | Q9BXC0 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | XDH | P47989 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31455886 | 1.00 | CA12 (0.76) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17274803 | 1.00 | CA12 (0.76) | CA12CA1CA2CA7CA9 | |
| SCHEMBL46504 | 0.91 | CA12 (0.91) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9121827 | 0.91 | CA12 (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7234945 | 0.91 | CA12 (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8413910 | 0.90 | CA12 (0.68) | CA12CA1CA2CA7CA9 | |
| Methyl Alcohol SCHEMBL28269742 | 0.89 | CA12 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10932231 | 0.87 | CA12 (0.63) | CA12CA1CA2CA7CA9 | |
| Methyl 3,5-Dihydroxybenzoate SCHEMBL38869 | 0.87 | CA1 (1.00) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2624952 | 0.83 | CA12 (0.76) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109485573-B | Aromatic dicarboxylic acid ionic liquid and preparation method and application thereof | 宝鸡文理学院 | 2021-04-30 | — | — | CN | disclosed |
| US-20170143706-A1 | SELECTIVE KINASE INHIBITORS | GOLUB CAPITAL LLC, AS COLLATERAL AGENT | 2017-05-25 | — | — | US | disclosed |
| US-8410151-B2 | Aminomethyl benzene derivatives | ACTELION PHARMACEUTICALS LTD (CH) | 2013-04-02 | — | — | US | disclosed |
| EP-2262782-B1 | NOVEL AMINOMETHYL BENZENE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2012-07-04 | — | — | EP | disclosed |
| WO-2012019428-A1 | BENZOHYDROL DERIVATIVES, A PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF | 上海恒瑞医药有限公司 (CN) | 2012-02-16 | — | — | WO | disclosed |
| CN-102083884-A | Copolyester for shrink film applications | INVISTA TECH SARL | 2011-06-01 | — | — | CN | disclosed |
| US-20110028449-A1 | NOVEL AMINOMETHYL BENZENE DERIVATIVES | ACTELION PHARMACEUTICALS LTD. (CH) | 2011-02-03 | — | — | US | disclosed |
| EP-2262782-A1 | NOVEL AMINOMETHYL BENZENE DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2010-12-22 | — | — | EP | disclosed |
| EP-1528063-B1 | COMPOUND HAVING PHOSPHORYLCHOLINE GROUP, POLYMER THEREOF, AND PROCESS FOR PRODUCING THE SAME | UNIV TOKAI (JP) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009109904-A1 | NOVEL AMINOMETHYL BENZENE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2009-09-11 | — | — | WO | disclosed |
| US-20060041160-A1 | Compound having phosphorylcholine group, polymer thereof and process for producing the same | TOKAI UNIVERSITY (JP) | 2006-02-23 | — | — | US | disclosed |
| EP-1528063-A1 | COMPOUND HAVING PHOSPHORYLCHOLINE GROUP, POLYMER THEREOF, AND PROCESS FOR PRODUCING THE SAME | Tokai University (JP) | 2005-05-04 | — | — | EP | disclosed |
| US-6689922-B1 | BIAROMATIC COMPOUNDS WHICH ARE ANALOGUES OF VITAMIN D HAVE A MARKED ACTIVITY IN THE FIELDS OF CELL DIFFERENTIATION AND PROLIFERATION | GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) | 2004-02-10 | — | — | US | disclosed |
| EP-0707572-A1 | IODINATED OLIGOMERIC COMPOUNDS AND DIAGNOSTIC COMPOSITIONS CONTAINING THE SAME | BRACCO S.p.A. (IT) | 1996-04-24 | — | — | EP | disclosed |
| WO-1995013270-A1 | NOVEL TAXICINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1995-05-18 | — | — | WO | disclosed |
| WO-1995001966-A1 | IODINATED OLIGOMERIC COMPOUNDS AND DIAGNOSTIC COMPOSITIONS CONTAINING THE SAME | BRACCO S.P.A. (IT) | 1995-01-19 | — | — | WO | disclosed |
| EP-0538416-A4 | SUBSTITUTED MONOCYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY | RHONE POULENC RORER INT (US) | 1994-05-18 | — | — | EP | disclosed |
| US-5298652-A | N-substituted glycines, inhibitors of phospholipase A2 | HOFFMANN-LA ROCHE INC. (US) | 1994-03-29 | — | — | US | disclosed |
| EP-0538416-A1 | SUBSTITUTED MONOCYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY. | RHONE POULENC RORER INT (US) | 1993-04-28 | — | — | EP | disclosed |
| WO-1992004315-A1 | SUBSTITUTED MONOCYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1992-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060041160-A1 | Compound having phosphorylcholine group, polymer thereof and process for producing the same | PHOSPHO1, SGMS2, PCYT1A | CA12 326/4885CA1 2088/4885CA2 1078/4885 |
| US-20110028449-A1 | NOVEL AMINOMETHYL BENZENE DERIVATIVES | CD47, BRD4, BRD3 | CA12 4463/4885CA1 4716/4885CA2 4137/4885 |
| US-20170143706-A1 | SELECTIVE KINASE INHIBITORS | JAK3, JAK1, JAK2 | CA12 4343/4885CA1 4006/4885CA2 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.